Inactive Instrument
Alexza Pharmaceuticals, Inc. Stock Nasdaq
Stocks
US0153841004
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Stacy Palermini
DFI | Director of Finance/CFO | - | 01/01/2003 |
Wolfgang Schmidt
PRN | Corporate Officer/Principal | - | 01/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 21/06/2016 | |
| Director/Board Member | - | 21/06/2016 | |
| Director/Board Member | - | 21/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | -3.96% | +54.92% | +69.15% | 65.45B | ||
| -0.14% | -3.20% | +7.62% | +89.74% | 58.93B | ||
| +0.06% | +0.15% | +25.94% | +87.89% | 55.21B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 46.1B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 42.49B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 35.56B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.57B | ||
| +0.03% | -0.93% | +76.71% | +57.74% | 32.46B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 26.28B | ||
| Average | +2.25% | -3.08% | +34.71% | +179.62% | 44B | |
| Weighted average by Cap. | +1.27% | -2.90% | +34.22% | +149.70% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
















